Last reviewed · How we verify

NCT04030637

The Diagnostic Accuracy of Using Faecal-DNA Test (COLOSAFE) for Colorectal Cancer Screening

Status unknown Last updated 24 July 2019
What this trial tests

trial in To Evaluate the Sensitivity and Specificity of a Test Kit in Hong Kong in 400 participants. Status unknown.

Timeline
11 February 2019
Primary endpoint
1 January 2020
28 February 2020

Quick facts

Lead sponsorChinese University of Hong Kong
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment400
Start date11 February 2019
Primary completion1 January 2020
Estimated completion28 February 2020
Sites1 location across Hong Kong

Conditions studied

Sponsor

Chinese University of Hong Kong

Who can join

Adults 45 to 79, any sex, with To Evaluate the Sensitivity and Specificity of a Test Kit in Hong Kong. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the sensitivity and specificity of the test kit "COLOSAFE' in Hong Kong

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04030637.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing